Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease

Journal of Viral Hepatitis

Volumn 15, Issue 2, 2008, Pages 145-154

  Gigi, E ^a,b   Raptopoulou Gigi, M ^a   Kalogeridis, A ^a   Masiou, S ^a   Orphanou, E ^a   Vrettou, E ^a   Lalla, T H ^a   Sinakos, E ^a   Tsapas, V ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Chronic hepatitis C; Self limited HCV infection; TH1 TH2 cytokines

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; NONSTRUCTURAL PROTEIN 3; PLASMID VECTOR; RECOMBINANT DNA; RNA;

ADULT; AGED; ARTICLE; CELL CULTURE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TH1 CELL; TH2 CELL; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; CYTOKINES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 37649001186     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00908.x     Document Type: Article

References (32)

1. Alter HJ, Sheef LB. Recovery, persistence and sequelae in hepatitis C virus infection: a perspective on long term outcome. Semin Liver Dis 2000 20 : 17 35.
2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52.
3. Shiffman ML. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation. Liver Transpl 2003 9 : S14 S20.
4. Cerry A, Chisari FV. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence. Hepatology 1999 30 : 595 601.
5. Diepolder HM, Zachoval R, Hoffman RM et al. Possible mechanisms involving T lymhocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 346 : 1006 1007.
6. Tsai SL, Liaw YF, Chen MH, Huang CY, Kno GC. Detection of type-2 like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997 25 : 449 458.
7. Recherman B, Chang KM, McHutchison Y et al. Differential cytotoxic T lympocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996 70 : 7092 70102.
8. Diepolder RM, Gerttah JT, Zachoval R et al. Immunodominant CD4+T cell epitope within non-structural protein 3 in acute hepatitis C virus infection. J Virol 1997 71 : 6011 6019.
9. Chang KM, Thimme R, Melpoder JJ et al. Differential CD4+ and CD8+ T cell responsiveness in hepatitis C infection. Hepatology 2001 33 : 267 276.
10. Rosen HR, Miner C, Sasaki AW et al. Frequencies of HCV specific effect or CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 2002 35 : 190 198.
11. Nelson DR, Lau JYN. Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection. Clin Liver Dis 1997 1 : 515 529.
12. Muratori L, Gibellini D, Lenzi M et al. Quantification of hepatitis C virus infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1996 88 : 2768 2774.
13. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and post treatment with interferon-a. Hepatology 1996 24 : 6 9.
14. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in hepatitis C virus core-specific blood T lymphocytes. J Immunol 1997 159 : 1012 1018.
15. Reiser M, Marousis CG, Nelson DR et al. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 1997 26 : 471 478.
16. Shapiro S, Gershtein V, Ellias N, Zuckerman E, Salman N, Lahat N. MRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)- infected patients: effects of interferon-alpha (IFN-a) treatment. Clin Exp Immunol 1998 114 : 55 60.
17. Anthony DD, Post AB, Valdez H, Peterson DL, Murphy M, Heeger PS. Elispot analysis of hepatitis C virus protein-specific IFN-γ producing peripheral blood lymphocytes in infected humans with and without cirrhosis. Clin Immunol 2001 99 : 232 240.
18. Semmo N, Dey CL, Ward SM et al. Preferential loss of IL-2 secreting CD4+ T helper cells in chronic HCV infection. Hepatology 2005 41 : 1019 1028.
19. Bergamini A, Bolacchi F, Cerasari G et al. Lack of evidence of TH2 predominance in patients with chronic hepatitis C. Clin Exp Immunol 2001 123 : 451 458.
20. Takaki A, Wrese M, Maertens G et al. Cellular Immune responses persist and immune responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000 6 : 578 582.
21. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC. Immunobiology of hepatitis C Virus (HCV) infection: the role of CD4 T cells in HCV infection. Immunol Rev 2000 174 : 90 97.
22. Kakumu S, Okumura A, Ishikawa T et al. Serum levels of IL-10, IL-15 and soluble tumor necrosis factor alpha (TNF-a) receptors in type C chronic liver disease. Clin Exp Immunol 1997 109 : 458 463.
23. Eckels DD, Tabatabail N, Bian TH et al. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. Hum Immunol 1999 60 : 187 199.
24. - in patients with stable CD4 T cell responses to HAART. Clin Exp Immunol 2004 138 : 110 115.
25. Brown JE, Klemens JF, McAllister WT. Sequences of three promoters for the bacteriophage SP6 RNA polymerase. Nucleic Acids Res 1986 14 : 3521 3526.
26. Klemens JF, Ling ML, McAllister WT. Sequencing of DNA using T3 RNA polymerase and chain terminating ribonucleotide analogs. Gene Anal Tech 1986 3 : 59 66.
27. Peebles CL, Perlman PS, Mecklenburg KL et al. A self-splicing RNA excises an intron lariat. Cell 1986 44 : 213 223.
28. Kotewicz ML, D'Alessio JM, Driftmier KM, Blodgett KP, Gerard GF. Cloning and over expression of Moloney murine leukemia virus reverse transcriptase in Escherichia Coli. Gene 1985 35 : 249 258.
29. Houts GE, Miyagi M, Ellis C, Beard A, Beard JW. Reverse transcriptase from avian myeloblastosis virus. J Virol 1979 29 : 517 522.
30. Tsai SL, Chen YM, Chen MH et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology 1998 115 : 954 965.
31. Shirren CA, Jung MC, Gerlach JT. Liver-derived hepatitis C virus-specific CD4+T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000 32 : 597 603.
32. Gerlach JT, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T cell response in acute hepatitis C. Gastroenterology 1999 117 : 933 941.